Diagnosis and Risk Stratification of non-alcoholic Steatohepatitis (NASH) - a Recommendation from Austrian Hepatologists

被引：0

作者：

Munda, Petra ^{[1
]}

Aigner, Elmar ^{[2
]}

Ferlitsch, Arnulf ^{[3
]}

Gschwantler, Michael ^{[4
]}

Hofer, Harald ^{[5
]}

Maieron, Andreas ^{[6
]}

Peck-Radosavljevic, Markus ^{[7
]}

Stadlbauer-Koellner, Vanessa ^{[8
]}

Wagner, Martin ^{[8
]}

机构：

[1] Med Univ Wien, AKH Wien, Vienna, Austria

[2] Paracelsus Med Privatuniv, Uniklinikum Salzburg, PMU, Salzburg, Austria

[3] KH Barmherzige Bruder Wien, Vienna, Austria

[4] KA Wilhelminenspital, Vienna, Austria

[5] Klinikum Wels Grieskirchen, Wels, Austria

[6] Univ Klinikum St Polten, St Polten, Austria

[7] Klinikum Klagenfurt Worthersee, Klagenfurt, Austria

[8] Med Univ Graz, Graz, Austria

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2020年 / 132卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P09

引用

页码：78 / 78

页数：1

共 50 条

[1] Non-alcoholic steatohepatitis (NASH)
Michael F. Sorrell
Sandeep Mukherjee
Current Treatment Options in Gastroenterology, 1999, 2 (6) : 447 - 450
[2] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
Roeb, Elke
DRUG RESEARCH, 2021, 71 : S16 - S18
[3] Non-alcoholic steatohepatitis (NASH): Is a liver biopsy necessary for diagnosis?
Byrne, T
Douglas, DDD
Harrison, ME
Nelson, L
HEPATOLOGY, 1997, 26 (04) : 1037 - 1037
[4] Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
Liu C.-H.
Habig G.
Smaltz C.
Halegoua-DeMarzio D.
Current Hepatology Reports, 2021, 20 (4) : 117 - 127
[5] Therapies in non-alcoholic steatohepatitis (NASH)
Oseini, Abdul M.
Sanyal, Arun J.
LIVER INTERNATIONAL, 2017, 37 : 97 - 103
[6] Depression and anxiety as risk factors for non-alcoholic steatohepatitis (NASH)
Elwing, JE
Lustman, PJ
Wang, HL
Clouse, RE
GASTROENTEROLOGY, 2005, 128 (04) : A767 - A767
[7] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
Cortez-Pinto, H
Camilo, ME
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
[8] State of the art on the pathophysiology, diagnosis and treatment of non-alcoholic steatohepatitis (NASH)
Grzych, G.
Bernard, L.
Lestrelin, R.
Tailleux, A.
Staels, B.
ANNALES PHARMACEUTIQUES FRANCAISES, 2023, 81 (02): : 183 - 201
[9] Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
Cuadrado, A
Orive, A
García-Suárez, C
Domínguez, A
Fernández-Escalante, JC
Crespo, J
Pons-Romero, F
OBESITY SURGERY, 2005, 15 (03) : 442 - 446
[10] Effect of phlebotomy on non-alcoholic steatohepatitis (NASH).
Nitecki, J
Jackson, FW
Allen, ML
Farr, VL
Jackson, FW
GASTROENTEROLOGY, 2000, 118 (04) : A1474 - A1474

← 1 2 3 4 5 →